Hyung-Kwam Kim, MD, PhD, Seoul National University, Republic of Korea
Sang-Chol Lee, MD, PhD, Sungkyunkwan University, Republic of Korea
The Journal of Cardiovascular Imaging is calling for submissions to our Collection on Innovative Approaches to Hypertrophic Cardiomyopathy.
Image credit: © Rasi / stock.adobe.com
Hyung-Kwam Kim, MD, PhD, Seoul National University, Republic of Korea
Prof. Hyung-Kwan Kim is a cardiologist and professor at Seoul National University College of Medicine, Korea. He is Director of the Cardiac Diagnostic Test Unit and Head of General Clinical Trials at Seoul National University Hospital. Earning his MD and PhD from Seoul National University, he began as a clinical assistant professor in 2008. Prof. Kim has published over 220 SCI papers and is Editor-in-Chief of Cardiovascular Imaging. His research spans hypertrophic cardiomyopathy, valvular heart disease, and pulmonary hypertension.
Sang-Chol Lee, MD, PhD, Sungkyunkwan University, Republic of KoreaDr. Sang-Chol Lee is a cardiologist at Samsung Medical Center and a professor at Sungkyunkwan University School of Medicine. He specializes in echocardiography, heart failure, and cardiomyopathy, and currently serves as Director of the Heart Vascular and Stroke Institute of Samsung Medical Center. Dr. Lee has contributed to significant advancements in cardiovascular care with his research focusing on hypertrophic cardiomyopathy and multimodality imaging. He has been an active member of the Korean Society of Echocardiography and currently serves as the Secretary General of the society.
This Collection aims to address various aspects of hypertrophic cardiomyopathy. The recent introduction of cardiac myosin inhibitors has opened a new horizon for the management of hypertrophic cardiomyopathy. In light of this development, it is timely to review key issues surrounding hypertrophic cardiomyopathy, including heart failure, sudden cardiac death, arrhythmias such as atrial fibrillation, thromboembolic events like ischemic stroke, and genetics. We look forward to receiving cutting-edge research and review articles that explore these issues. We also welcome submissions that utilize new techniques, such as artificial intelligence or state-of-the-art echocardiographic or cardiac magnetic resonance imaging technologies, to enhance diagnostic accuracy and improve patient outcomes.
It aims to address a wide range of topics, including but not limited to:
All submissions will undergo peer review, which will be completed within 4 weeks as part of the Expedited Review process.
JCVI welcomes manuscripts that contribute to enhancing and widening our understanding of hypertrophic cardiomyopathy.
There are currently no articles in this collection.
This Collection welcomes submission of research and review articles. Should you wish to submit a different article type, please read our submission guidelines to confirm that type is accepted by the journal.
Articles for this Collection should be submitted via our submission system, Snapp. Please, select the appropriate Collection title “Innovative Approaches to Hypertrophic Cardiomyopathy" under the “Details” tab during the submission stage.
Articles will undergo the journal’s standard peer-review process [and are subject to all the journal’s standard policies. Articles will be added to the Collection as they are published.
All submissions will undergo peer review which will be completed within 4 weeks, as part of the Expedited Review process.
The Editors have no competing interests with the submissions which they handle through the peer-review process. The peer-review of any submissions for which the Editors have competing interests is handled by another Editorial Board Member who has no competing interests.